There is a growing demand for quality healthcare in China. Realizing this demand, US-based Cinpathogen has taken the opportunity to collaborate with the Institute of Biomedical Sciences at Fudan University in Shanghai, to form the Fudan–Cinpathogen Center for Clinical and Molecular Research.
"This partnership provides an unprecedented opportunity," said Dr Richard D Irons, Cinpathogen's CEO. "By integrating Western and Chinese medical research systems, we can advance global biomedical research and help satisfy China's growing demand for high-quality healthcare."
The Fudan–Cinpathogen Center for Clinical and Molecular research brings together clinical operations, modern diagnostic laboratories and access to one of the largest tissue banks dedicated to diseases of the blood and immune systems in order to support diagnosis and conduct protocol-driven research on the etiology, pathogenesis and treatment of disease.